Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study

O. Ahlehoff, L. Skov, G. Gislason, J. Lindhardsen, S. L. Kristensen, L. Iversen, S. Lasthein, R. Gniadecki, T. N. Dam, Christian Torp-Pedersen, P. R. Hansen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

161 Citationer (Scopus)

Abstract

Psoriasis is a chronic inflammatory disorder associated with cardiovascular morbidity and mortality. Systemic anti-inflammatory drugs, including biological agents, are widely used in the treatment of patients with moderate to severe psoriasis and may attenuate the risk of cardiovascular disease events. We therefore examined the rate of cardiovascular disease events in patients with severe psoriasis treated with systemic anti-inflammatory drugs.
OriginalsprogEngelsk
TidsskriftJournal of Internal Medicine
Vol/bind273
Udgave nummer2
Sider (fra-til)197-204
ISSN0954-6820
DOI
StatusUdgivet - 2013
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study'. Sammen danner de et unikt fingeraftryk.

Citationsformater